TIDMSUN
RNS Number : 6219V
Surgical Innovations Group PLC
05 December 2023
Surgical Innovations Group Plc
("Surgical Innovations", the "Company" or the "Group")
Directorate Change
Surgical Innovations appoints Keyvan Djamarani as Independent
Non-executive Director
Nigel Rogers steps down, concluding the Board succession
plan
Surgical Innovations Group Plc (AIM: SUN), the designer,
manufacturer and distributor of innovative technology for minimally
invasive surgery, announces that Keyvan Djamarani has been
appointed as Independent Non-executive Director with immediate
effect. This follows an extensive process led by an independent
head-hunter. At the same time Nigel Rogers, who previously served
time as Chair of the Company, will step down from the Board.
Keyvan has over 30 years' relevant experience, holding numerous
leadership roles in product development within manufacturing
organisations covering medical and pharmaceutical drug delivery
devices . He has a track record of delivering increased sales,
profitability and business critical programmes and projects. Most
recently he spent over nine years as Managing Director/Business
President at Bespak Europe, a medical and pharmaceutical drug
delivery devices business . Keyvan began his career at Unilever
working in their Detergents and Personal Products Divisions prior
to joining Bespak. At Bespak, Keyvan held several roles across
their European and North American divisions. Within this period,
from 2002 to 2005, Keyvan was General Manager and President of
Bespak Inc. and from 2010 to 2013, Keyvan became CEO of King
Systems, an airways management business, encompassing design,
development and manufacture of airway management products. Keyvan
was most recently a Non-executive Director of CEME Ltd, a
not-for-profit business enterprise operating on a 19-acre campus,
home to over 100 engineering, technology and training businesses -
a role he held for over 16 years.
As announced on 22 May 2023 , Nigel Rogers will step down from
the Board with immediate effect , concluding the final part of the
planned Board succession process. Nigel joined the Board in 2015,
bringing stability to the Company at a critical time.
Chair of the Company, Jonathan Glenn, commented: "I would like
to thank Nigel for the dedicated service he provided to Surgical
Innovations over his eight-year tenure, bringing the Company safely
through a number of significant challenges including the pandemic.
His experience proved invaluable and his insight has always been
appreciated by the Board and management.
"I am also delighted to welcome Keyvan to the Board. He has an
excellent track record in the medical device sector and brings with
him a broad and relevant skillset. His extensive operational
experience will provide a wealth of expertise to the Board,
affording valuable insight into the challenges of manufacturing as
the Company undertakes a major efficiency drive to improve
margins."
The following information is disclosed pursuant to Rule 17 and
Schedule Two paragraph (g) of the AIM Rules for Companies:
Dr Keyvan Mehdi Djamarani (aged 62) is currently, or has during
the past five years, been a director of the following
companies:
Current directorships or partnerships Previous directorships or partnerships
* n/a * Centre for Engineering and Manufacturing Excellence
Ltd
* Bespak Europe Limited
* Integrated Aluminium Components Limited
* The Medical House Group Limited
* The Medical House Limited
* The Medical House Products Limited
* Medical House (ASI) Limited
* Hyperlyser Limited
----------------------------------------------------------------
Save as set out in this announcement there are no further
details to be disclosed in accordance with Rule 17 and Schedule Two
Paragraph (g) of the AIM Rule for Companies.
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, CFO
Singer Capital Markets (Nominated Tel: 020 7496 3000
Adviser & Broker)
Aubrey Powell / Oliver Platts
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Charlotte Edgar Mob: 07980 541 893 / 07584
391 303
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part reusable,
part disposable, offering a high quality and environmentally
responsible solution at a cost that is competitive against fully
disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email, please contact
si@walbrookpr.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAUPGUUPUPWGMC
(END) Dow Jones Newswires
December 05, 2023 02:00 ET (07:00 GMT)
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
